Nastech to Present at Acumen BioFin Rodman & Renshaw Healthcare Conference

BOTHELL, Wash., Oct. 31 /PRNewswire-FirstCall/ -- Nastech Pharmaceutical Company Inc. announced today that it will present at the Acumen BioFin Rodman & Renshaw Healthcare Conference on Monday, November 5, 2007 at 2:40 p.m. Eastern Time at the New York Palace Hotel in New York City.

To access the live audio webcast for this conference, please log on to Nastech's website at http://www.nastech.com/ approximately 15 minutes prior to the presentation in order to register and download any necessary software. A replay of the audio presentation will be available following the event.

About Nastech

Nastech is a biopharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. Nastech and our collaboration partners are developing products for multiple therapeutic areas including osteoporosis, obesity, diabetes, autism, respiratory diseases and inflammatory conditions. Additional information about Nastech is available at http://www.nastech.com/.

CONTACTS: Nastech Ed Bell Director, Investor Relations (425) 908-3639 ir@nastech.com Russo Partners / LLC David Schull (Media) (212) 845-4271

Nastech Pharmaceutical Company Inc.

CONTACT: Ed Bell, Director, Investor Relations of Nastech,
1-425-908-3639, ir@nastech.com; or Media: David Schull of Russo Partners-LLC
for Nastech Pharmaceutical Company Inc. 1-212-845-4271

Web site: http://www.nastech.com/